AstraZeneca stock posts 0.00 percent weekly change at EUR 142.23. High reached EUR 143.95.
Published on 10/10/2026 at 10:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Lang & Schwarz quoted AstraZeneca at EUR 142.23 in weekend trading on October 10, 2026.
- The weekly high was EUR 143.95 and the weekly low was EUR 140.35.
- AstraZeneca completed a $2 billion equity investment in Summit Therapeutics on October 5, 2026.
AstraZeneca stock posted a 0.00 percent change at EUR 142.23 in weekend trading at Lang & Schwarz at 10:33 a.m. CEST on October 10, 2026, compared with the EUR 142.23 close at Lang & Schwarz on October 9, 2026.
Market context: Market report FTSE 100.
The week in figures
Lang & Schwarz quoted AstraZeneca at EUR 142.23 on October 10, 2026. The reported weekly high was EUR 143.95, while the weekly low was EUR 140.35. The current quote was unchanged against the EUR 142.23 close at Lang & Schwarz on October 9, 2026.
The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Chronology of the week
On October 5, 2026, AstraZeneca announced the successful completion of its $2 billion equity investment in Summit Therapeutics. The company said the investment would accelerate development of ivonescimab in combination with antibody drug conjugates across tumor types. AstraZeneca published the announcement.
Dates of the coming week
The next Xetra session is dated October 12, 2026. No additional company date is included here.
